Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.
Sarah S. Donaldson(Stanford University), Moody D. Wharam(Johns Hopkins University), Fran Laurie(University of Massachusetts Chan Medical School), William M. Crist(St. Jude Children's Research Hospital), Jane L. Meza(Children's Oncology Group), Stephen J. Qualman(Nationwide Children's Hospital), John C. Breneman(University of Cincinnati)
International Journal of Radiation Oncology*Biology*Physics
November 1, 2001
Cited by 213
Related Papers
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1991|722
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
|International Journal of Radiation Oncology*Biology*Physics|2002|508